| |
| Device | Trufill n-Butyl Cyanoacrylate (n-BCA) Liquid Embolic System |
| Generic Name | tissue adhesive for use in embolization of brain arteriovenous malformations |
| Applicant | Cerenovus, Inc. 6303 Waterford District Dr. Suite 315 Miami, FL 33126 |
| PMA Number | P990040 |
| Supplement Number | S027 |
| Date Received | 11/02/2018 |
| Decision Date | 03/22/2019 |
| Product Code |
KGG |
| Advisory Committee |
Neurology |
| Supplement Type | Normal 180 Day Track No User Fee |
| Supplement Reason | Location Change - Manufacturer/Sterilizer/Packager/Supplier |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement Approval for a manufacturing site located at Chemence Medical Products, Inc., 200 Technology Drive, Alpharetta, Georgia, for the manufacturing and sterilization of the n-butyl cyanoacrylate (n-BCA) component of the TRUFILL n-BCA Liquid Embolic System. |